09.02.2014 Views

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

home edit2 whole TSD November 2002 PDF format - OEHHA

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

still alive in the low-dose control, high-dose control, low-dose and high-dose groups, respectively. In<br />

male rats, 54% of the controls, 64% of low-dose and 70% of high-dose animals were alive at the end<br />

of the study. Insufficient numbers of female rats survived to the latter portion of the experimental period<br />

to permit analysis of late-developing tumors.<br />

High-dose male and female mice demonstrated a significantly increased incidence of hepatocellular<br />

carcinomas. Tumor incidence in male mice was 12/46 in low-dose controls, 6/48 in high-dose controls,<br />

20/47 in low-dose animals, and 36/49 (p < 0.001) in high-dose animals; in female mice, the frequencies<br />

were 4/46, 1/50, 5/47 and 12/47 (p < 0.001) (NCI, 1978; Murthy et al., 1979). A dose-dependent<br />

increase in hepatic neoplastic nodules and hepatocellular carcinomas (p < 0.001) was noted in 18/41<br />

low-dose and 18/45 high dose males; tumors were observed in 0/36 control male rats.<br />

IV.<br />

DERIVATION OF CANCER POTENCY<br />

Basis for Cancer Potency<br />

The NCI carcinogenicity bioassay of 2-AA indicated that 2-AA induced tumor <strong>format</strong>ion in both rats<br />

and mice. The cancer potency value derived is based on the dose-response data for hepatic tumors in<br />

the more sensitive sex and species, the male rat (Cal/EPA, 1992).<br />

Methodology<br />

Expedited Proposition 65 methodology (with cross-route extrapolation) was used to derive a cancer<br />

potency factor. The average dose administered to the male rat high-dose group as calculated by Gold<br />

et al. (1984) was 102 mg/kg/day. Analysis of the data set using the computer program TOX_RISK<br />

(Crump et al., 1991) indicated that inclusion of the high dose group resulted in a p-value of = 0.05<br />

based on the chi-square goodness-of-fit test, indicating non-linearity. Following procedures described<br />

by US EPA (Anderson et al., 1983), the high dose group was excluded from the analysis to correct for<br />

the poor fit (Cal/EPA, 1992). A unit risk factor was then calculated by <strong>OEHHA</strong>/ATES from the<br />

cancer potency factor using a reference human body weight of 70 kg and an inspiration rate of 20<br />

m 3 /day.<br />

V. REFERENCES<br />

Anderson EL and the Carcinogen Assessment Group of the U.S. Environmental Protection Agency<br />

1983. Quantitative approaches in use to assess cancer risk. Risk Anal 3:277-295.<br />

Crump KS, Howe RB, Van Landingham C and Fuller WG. 1991. TOXRISK Version 3. TOXicology<br />

RISK Assessment Program. KS Crump Division, Clement International Division, 1201 Gaines Street,<br />

Ruston LA 71270.<br />

56

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!